Ajax-Loading

Hansoh Pharmaceutical Group Co Ltd - Price To Sales Ratio

Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 13.05 as of 06/30/2025, the highest value at least since 12/31/2023, the period currently displayed.

As of the end of Hansoh Pharmaceutical Group Co Ltd's second quarter, the item "Price To Sales Ratio" stands at 13.05. This represents an increase of 11.78 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 51.01 percent compared to the value the year prior.
The 1 year change in percent is 51.01.

The Serie's long term average value is 9.96. It's latest available value, on 06/30/2025, is 31.02 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 06/30/2025, is +100.26%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.

Price To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Sales Ratio905,699,262,464.00
LogoJohnson & Johnson - Price To Sales Ratio486,508,953,600.00
LogoAbbVie Inc - Price To Sales Ratio399,570,305,024.00
LogoRoche Holding AG - Price To Sales Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price To Sales Ratio280,205,508,085.11